Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126548651 | 12654865 | 1 | I | 20160805 | 20160816 | 20160816 | EXP | IN-PFIZER INC-2016386152 | PFIZER | 16.00 | YR | F | Y | 0.00000 | 20160816 | MD | IN | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126548651 | 12654865 | 1 | PS | CEFUROXIME. | CEFUROXIME | 1 | Oral | 5 DAYS | U | 65483 | |||||||||
| 126548651 | 12654865 | 2 | SS | CEFUROXIME. | CEFUROXIME | 1 | U | 65483 | |||||||||||
| 126548651 | 12654865 | 3 | C | NORFLOX /00668101/ | 2 | Oral | FIRST 3 DAYS | 0 | |||||||||||
| 126548651 | 12654865 | 4 | C | NORFLOX /00668101/ | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126548651 | 12654865 | 1 | Pyrexia |
| 126548651 | 12654865 | 2 | Chills |
| 126548651 | 12654865 | 3 | Pyrexia |
| 126548651 | 12654865 | 4 | Chills |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126548651 | 12654865 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126548651 | 12654865 | Drug ineffective | |
| 126548651 | 12654865 | Typhoid fever |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |